Alibaba Health Information Technology Ltd
Company Profile
Business description
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba’s Tmall app and Alipay. The company also provides online consultation services in a separate app called Yilu or “Dr. Deer,” although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
Contact
Wangjing East Park
30th Floor, Greenland Center
Building 9, Zone 4
Chaoyang District
Beijing
CHNSector
Healthcare
Stock type
Defensive
Industry
Pharmaceutical Retailers
Fiscal Year End
31 March 2026
Employees
1,364
Stocks News & Analysis
stocks
Market Minute: RBA cuts rates again, US CPI data released
stocks
Is the market still overlooking Alibaba’s AI potential?
stocks
ASX reporting season wrap: CBA, JB Hi-Fi, REA and more
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,212.10 | 63.00 | 0.69% |
CAC 40 | 7,923.45 | 53.11 | 0.67% |
DAX 40 | 24,359.30 | 18.20 | -0.07% |
Dow JONES (US) | 44,946.12 | 34.86 | 0.08% |
FTSE 100 | 9,138.90 | 38.34 | -0.42% |
HKSE | 25,270.07 | 249.25 | -0.98% |
NASDAQ | 21,622.98 | 87.69 | -0.40% |
Nikkei 225 | 43,378.31 | 729.05 | 1.71% |
NZX 50 Index | 12,889.38 | 55.30 | 0.43% |
S&P 500 | 6,449.80 | 18.74 | -0.29% |
S&P/ASX 200 | 8,938.60 | 64.80 | 0.73% |
SSE Composite Index | 3,696.77 | 30.33 | 0.83% |